Cargando…

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

BACKGROUND: Stromal tumor-infiltrating lymphocytes (TILs) are a robust prognostic factor in triple-negative breast cancer (TNBC). However, the clinical significance of TILs may be influenced by the complex landscape of the tumor immune microenvironment. In this study, we aimed to evaluate the compos...

Descripción completa

Detalles Bibliográficos
Autores principales: Bottai, Giulia, Raschioni, Carlotta, Losurdo, Agnese, Di Tommaso, Luca, Tinterri, Corrado, Torrisi, Rosalba, Reis-Filho, Jorge S., Roncalli, Massimo, Sotiriou, Christos, Santoro, Armando, Mantovani, Alberto, Loi, Sherene, Santarpia, Libero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135782/
https://www.ncbi.nlm.nih.gov/pubmed/27912781
http://dx.doi.org/10.1186/s13058-016-0783-4
_version_ 1782471606998663168
author Bottai, Giulia
Raschioni, Carlotta
Losurdo, Agnese
Di Tommaso, Luca
Tinterri, Corrado
Torrisi, Rosalba
Reis-Filho, Jorge S.
Roncalli, Massimo
Sotiriou, Christos
Santoro, Armando
Mantovani, Alberto
Loi, Sherene
Santarpia, Libero
author_facet Bottai, Giulia
Raschioni, Carlotta
Losurdo, Agnese
Di Tommaso, Luca
Tinterri, Corrado
Torrisi, Rosalba
Reis-Filho, Jorge S.
Roncalli, Massimo
Sotiriou, Christos
Santoro, Armando
Mantovani, Alberto
Loi, Sherene
Santarpia, Libero
author_sort Bottai, Giulia
collection PubMed
description BACKGROUND: Stromal tumor-infiltrating lymphocytes (TILs) are a robust prognostic factor in triple-negative breast cancer (TNBC). However, the clinical significance of TILs may be influenced by the complex landscape of the tumor immune microenvironment. In this study, we aimed to evaluate the composition and the functionality of lymphocytic infiltration and checkpoint receptors in TNBC. METHODS: Formalin-fixed, paraffin-embedded tissues were retrospectively collected from a cohort of patients with early-stage TNBC treated with adjuvant anthracycline-based chemotherapy (n = 259). Results were validated in an independent cohort of patients with TNBC (n = 104). Stromal TILs were evaluated on hematoxylin-and-eosin-stained sections. The density of CD4+, CD8+, and FOXP3+ lymphocytes, and the expression of the immune checkpoints PD-1 and LAG-3, were assessed by immunohistochemical analysis. RESULTS: The presence of elevated TILs positively correlated with the density of all T cell subtypes, especially cytotoxic CD8+ lymphocytes. We showed that increasing stromal TILs assessed as a continuous variable is an independent prognostic marker of prolonged relapse-free survival and overall survival in TNBC. Among immune subpopulations, CD8+ lymphocytes are the main effectors of anti-tumor immune responses. In two independent cohorts, we found that PD-1 and LAG-3 were concurrently expressed in approximately 15% of patients with TNBC. The expression of both checkpoint receptors positively correlated with the presence of TILs, but was not significantly associated with patient outcome. CONCLUSIONS: Overall, our data indicate that the evaluation of stromal TILs remains the most reliable immune prognostic marker in TNBC, and support the clinical evaluation of anti-PD-1/PD-L1 and anti-LAG-3 in a subset of patients with TNBC who have concurrent expression of both checkpoint receptors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-016-0783-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5135782
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51357822016-12-15 An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers Bottai, Giulia Raschioni, Carlotta Losurdo, Agnese Di Tommaso, Luca Tinterri, Corrado Torrisi, Rosalba Reis-Filho, Jorge S. Roncalli, Massimo Sotiriou, Christos Santoro, Armando Mantovani, Alberto Loi, Sherene Santarpia, Libero Breast Cancer Res Research Article BACKGROUND: Stromal tumor-infiltrating lymphocytes (TILs) are a robust prognostic factor in triple-negative breast cancer (TNBC). However, the clinical significance of TILs may be influenced by the complex landscape of the tumor immune microenvironment. In this study, we aimed to evaluate the composition and the functionality of lymphocytic infiltration and checkpoint receptors in TNBC. METHODS: Formalin-fixed, paraffin-embedded tissues were retrospectively collected from a cohort of patients with early-stage TNBC treated with adjuvant anthracycline-based chemotherapy (n = 259). Results were validated in an independent cohort of patients with TNBC (n = 104). Stromal TILs were evaluated on hematoxylin-and-eosin-stained sections. The density of CD4+, CD8+, and FOXP3+ lymphocytes, and the expression of the immune checkpoints PD-1 and LAG-3, were assessed by immunohistochemical analysis. RESULTS: The presence of elevated TILs positively correlated with the density of all T cell subtypes, especially cytotoxic CD8+ lymphocytes. We showed that increasing stromal TILs assessed as a continuous variable is an independent prognostic marker of prolonged relapse-free survival and overall survival in TNBC. Among immune subpopulations, CD8+ lymphocytes are the main effectors of anti-tumor immune responses. In two independent cohorts, we found that PD-1 and LAG-3 were concurrently expressed in approximately 15% of patients with TNBC. The expression of both checkpoint receptors positively correlated with the presence of TILs, but was not significantly associated with patient outcome. CONCLUSIONS: Overall, our data indicate that the evaluation of stromal TILs remains the most reliable immune prognostic marker in TNBC, and support the clinical evaluation of anti-PD-1/PD-L1 and anti-LAG-3 in a subset of patients with TNBC who have concurrent expression of both checkpoint receptors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-016-0783-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-03 2016 /pmc/articles/PMC5135782/ /pubmed/27912781 http://dx.doi.org/10.1186/s13058-016-0783-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bottai, Giulia
Raschioni, Carlotta
Losurdo, Agnese
Di Tommaso, Luca
Tinterri, Corrado
Torrisi, Rosalba
Reis-Filho, Jorge S.
Roncalli, Massimo
Sotiriou, Christos
Santoro, Armando
Mantovani, Alberto
Loi, Sherene
Santarpia, Libero
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
title An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
title_full An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
title_fullStr An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
title_full_unstemmed An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
title_short An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
title_sort immune stratification reveals a subset of pd-1/lag-3 double-positive triple-negative breast cancers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135782/
https://www.ncbi.nlm.nih.gov/pubmed/27912781
http://dx.doi.org/10.1186/s13058-016-0783-4
work_keys_str_mv AT bottaigiulia animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT raschionicarlotta animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT losurdoagnese animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT ditommasoluca animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT tinterricorrado animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT torrisirosalba animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT reisfilhojorges animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT roncallimassimo animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT sotiriouchristos animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT santoroarmando animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT mantovanialberto animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT loisherene animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT santarpialibero animmunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT bottaigiulia immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT raschionicarlotta immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT losurdoagnese immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT ditommasoluca immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT tinterricorrado immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT torrisirosalba immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT reisfilhojorges immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT roncallimassimo immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT sotiriouchristos immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT santoroarmando immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT mantovanialberto immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT loisherene immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers
AT santarpialibero immunestratificationrevealsasubsetofpd1lag3doublepositivetriplenegativebreastcancers